Download PDF
1
/
Pages
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89
First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: A retrospective observational study (RETOSS-ENDO)
Antonio Pérez Pérez; Emilio Ortega Martínez de Victoria; Francisco Arrieta Blanco; Assumpta Caixàs Pedragós; Estefanía Santos Mazo; Pablo Fernandez-Catalina; Sergio Martínez-Hervas; José Antonio López-Medina; Lorena Suárez-Gutiérrez; Juan Ramón Urgeles Planelles; Sònia Gatell Menchén; Francisco Tinahones Madueño;
Endocrinol Diabetes Nutr. 2022;69:540-2
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19
Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18